Medifast, Inc.
Medifast, Inc.（MED）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
med · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Hold
12 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$12.00
-0.8% upside
Low
$12.00
Median: $12 · Last Close: $12.10
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $11.96 | ↓ 1.16% |
1-day model range: $11.86–$12.06. Peak: $12.06 (-1.16%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $6 | -50.0% |
| 2028 | $5 | -62.5% |
| 2029 | $4 | -67.2% |
| 2030 | $4 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MED · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-02-19 | Stephens & Co. | Maintains | Equal Weight→Equal Weight |
| 2025-02-19 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-11-05 | DA Davidson | Upgrade ↑ | Underperform→Neutral |
| 2024-07-22 | DA Davidson | Maintains | Underperform→Underperform |
| 2024-06-05 | DA Davidson | Downgrade ↓ | Neutral→Underperform |
| 2024-04-30 | DA Davidson | Maintains | Neutral→Neutral |
| 2024-02-21 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-08-08 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-07-31 | DA Davidson | Maintains | Neutral→Neutral |
| 2023-05-02 | DA Davidson | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Medifast, Inc. (MED) stock. Of the recent 52 rating actions, 6 were upgrades and 9 were downgrades. 12 analysts currently cover MED.
分析师推荐趋势
MED analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$770M
↑ 101.6% YoY
Revenue Next Year
$602M
↓ 21.9% YoY
EPS This Year
$2.69
EPS Next Year
$1.78
↓ 33.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast MED EPS of $2.69 for the current fiscal year, based on estimates from 1 analysts. The MED revenue forecast is $770M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MED 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MED 的共识目标价为 $12.00（-0.8% 上行空间），分析师共识为 Hold。
MED 的短期预测（明日）为 $11.96（-1.16%）。 MED 对 2027 年的股价预测均值为 $6。 MED 对 2030 年的预测区间为 $3–$4。
Medifast, Inc. 在 NYSE 上市，代码 MED。MED 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 33% 对应 Hold 共识。
常见问题
MED 预测 · 8 个问题根据 12 位华尔街分析师，MED 的 12 个月平均目标价为 $12.00，最高 $12.00、最低 $12.00。若有图表，中位目标价可在上方查看。相对当前价 $12.10，隐含约 -0.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.